Candriam Luxembourg S.C.A. »

Enliven Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 609k 20.47
2025-06-30 $8.4M 417k 20.06